The benefits of in ovo vaccination are now within the
reach of many more hatcheries worldwide, thanks to the development of a
new compact device.
Embrex* Inovoject* m is a semi-automated in ovo vaccination
system from Pfizer Animal Health Global Poultry designed for those
hatcheries that do not have a large enough footprint or throughput to
justify the installation of a full-size Embrex Inovoject. The new device
allows these hatcheries to benefit from the improved accuracy,
reliability and efficiency of in ovo vaccination, but in a more
compact form.
Full technical details for the new Inovoject m will be unveiled at the
International Poultry Expo in Atlanta, Georgia in January 2012.
According to Melinda Freson, senior manager, BioDevice Marketing, Pfizer
Animal Health Global Poultry, the new device will include the same core
features of the larger Inovoject in a more condensed package.
“There has been a need for a smaller Inovoject for some time,” said
Melinda Freson. “For smaller hatcheries, or those in developing
countries which have traditionally relied on manual labor to vaccinate
each bird individually after hatch, the availability of a semi-automated in
ovo vaccination system that is the right size for their hatchery,
will be a real breakthrough.”
Embrex Inovoject has been at the forefront of in ovo technology
for over 20 years. In the US, more hatcheries use Embrex Inovoject than
any other in ovo vaccination system. The full-size Inovoject can
vaccinate up to 70,000 eggs per hour (configuration dependent), whereas
Inovoject m is designed for a throughput of between 12,000 and 20,000
eggs per hour.
A more modest device in a compact size means that more hatcheries will
be able to switch from manual subcutaneous vaccination and thus improve
flock health by protecting birds prior to hatch.
“The Inovoject m has a number of operational advantages for the producer
who currently vaccinates chicks on day of hatch,” said Freson. “Not
least is the fact that chicks can be transferred out of the hatchery and
into the grow-out environment sooner.”
As with all Embrex Inovoject devices, Inovoject m will be supported by
the Pfizer Global Poultry technical service and support team. The new
device will be unveiled to the public for the first time at a special
invitation-only event at IPE. Ask your local Pfizer representative for
details.
* Embrex Inovoject is a trademark of Pfizer Inc. or its affiliates
About Pfizer Animal Health Global Poultry
Pfizer Animal Health Global Poultry is a leading provider of innovative,
high-performance poultry health solutions to the global poultry industry.
Pfizer Global Poultry is committed to delivering reliable products
combined with world-class customer service that the global poultry
industry has grown to depend on to enhance bird performance and improve
poultry operations. For more information about Pfizer Global Poultry
visit www.pfizerglobalpoultry.com
About Pfizer Animal Health
Pfizer Animal Health, a business unit of Pfizer Inc., is a world leader
in the discovery, development and manufacture of innovative animal
health vaccines, medicines, diagnostic products and genetic tests.
Pfizer Animal Health invests more in research and development than any
other animal health company. We work to assure a safe, sustainable
global food supply from healthy beef and dairy cattle, swine, poultry,
sheep and fish while helping dogs, cats and horses live healthier longer
lives. We strive to be the animal health company that provides full
healthcare solutions to veterinarians, livestock producers, and pet
owners. To learn more, visit https://animalhealth.pfizer.com.
Pfizer Media:
Jessica Rasmussen
Jessica.rasmussen@pfizer.com
or
Garnett Keeler Media:
Mike Keeler
Mike.keeler@garnettkeeler.com